Overview

SER100 in Isolated Systolic Hypertension

Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
Isolated Systolic Hypertension (ISH)is the dominating hypertensive disease in elderly people. Much attention has recently been drawn to the strong relationship between the systolic blood pressure and cardiovascular morbidity. In previous clinical studies carried out in individuals with normal blood pressure at baseline SER100 decreased primarily the systolic blood pressure. It is hypothesized that the effect on systolic blood pressure in hypertensive patients will be larger or equal to the fall seen in normotensive patients.
Phase:
Phase 2
Details
Lead Sponsor:
Serodus ASA
Collaborators:
Smerud Medical Research International AS
The Research Council of Norway